New England Journal of Medicine, 375 (19), 18341844
For more on the research landscape, see our overview of GHK-Cu: The Anti-Aging Copper Peptide
The findings were confirmed using an ex vivo human placenta perfusion model and multiphoton microscopy
doi: 10.1038/s41586-020-2012-7 Summary Keywords COVID-19, diabetes, DPP-4 inhibitors, fibrosis, multi-organ injury Citation Smelcerovic A, Kocic G, Gajic M, Tomovic K, Djordjevic V, Stankovic-Djordjevic D and Anderluh M (2020) DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19A Therapeutic Approach of Choice in Type 2 Diabetic Patients
January 13, 2026
CB1 can upregulate the expression of SCD1 and FADS2 to promote erastin/RSL3-induced ferroptosis via the AKT and ERK pathways in triple-negative breast cancer (TNBC) cells [114]